MIRA Pharmaceuticals, Inc.
MIRA
$0.96
-$0.01-1.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.98% | 38.98% | 39.26% | 35.93% | 34.46% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 230.51% | -70.25% | -73.75% | -72.80% | -76.26% |
| Change in Net Operating Assets | -252.91% | -1,815.76% | -888.46% | 11.92% | 158.03% |
| Cash from Operations | 16.16% | -11.30% | -29.03% | -36.27% | -22.68% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -83.77% | -- | -- |
| Total Debt Repaid | -- | 101.42% | 100.00% | 102.08% | 100.00% |
| Issuance of Common Stock | 118.89% | 26.27% | -60.11% | -60.11% | -60.15% |
| Repurchase of Common Stock | -- | 99.75% | 99.75% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -260.36% | -182.17% | 101.96% | 51.37% | 145.82% |
| Cash from Financing | 115.66% | 24.84% | -46.95% | -52.47% | -56.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 298.58% | 12.81% | -174.79% | -165.84% | -141.62% |